Ariño H, Armangue T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M, Lancaster E, Saiz A, Dalmau J, Graus F (2016) Anti-LGI1-associated cognitive impairment: presentation and long-term outcome. Neurology 87:759–765. https://doi.org/10.1212/WNL.0000000000003009
Article CAS PubMed PubMed Central Google Scholar
Augener W, Grey HM, Cooper NR, Muller-Eberhard HJ (1971) The reaction of monomeric and aggregated immunoglobulins with C1. Immunochemistry 8:1011–1020. https://doi.org/10.1016/0019-2791(71)90489-7
Article CAS PubMed Google Scholar
Bien CG, Bien CI, Dogan Onugoren M, De Simoni D, Eigler V, Haensch C-A, Holtkamp M, Ismail FS, Kurthen M, Melzer N, Mayer K, von Podewils F, Rauschka H, Rossetti AO, Schäbitz W-R, Simova O, Witt K, Höftberger R, May TW (2020) Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome. J Neurol 267:2101–2114. https://doi.org/10.1007/s00415-020-09814-3
Article CAS PubMed PubMed Central Google Scholar
Bien CG, Vincent A, Barnett MH, Becker AJ, Blumcke I, Graus F, Jellinger KA, Reuss DE, Ribalta T, Schlegel J, Sutton I, Lassmann H, Bauer J (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135:1622–1638. https://doi.org/10.1093/brain/aws082
Bindon CI, Hale G, Bruggemann M, Waldmann H (1988) Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. J Exp Med 168:127–142. https://doi.org/10.1084/jem.168.1.127
Article CAS PubMed Google Scholar
Blümcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F, Bernasconi A, Bernasconi N, Bien CG, Cendes F, Coras R, Cross JH, Jacques TS, Kahane P, Mathern GW, Miyata H, Moshé SL, Oz B, Özkara Ç, Perucca E, Sisodiya S, Wiebe S, Spreafico R (2013) International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a task force report from the ILAE commission on diagnostic methods. Epilepsia 54:1315–1329. https://doi.org/10.1111/epi.12220
Celicanin M, Blaabjerg M, Maersk-Moller C, Beniczky S, Marner L, Thomsen C, Bach FW, Kondziella D, Andersen H, Somnier F, Illes Z, Pinborg LH (2017) Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies—a national cohort study. Eur J Neurol 24:999–1005. https://doi.org/10.1111/ene.13324
Article CAS PubMed Google Scholar
Dalakas MC (2022) Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia gravis. Expert Rev Clin Immunol 18:691–701. https://doi.org/10.1080/1744666x.2022.2082946
Article CAS PubMed Google Scholar
Dalmau J, Graus F (2023) Autoimmune encephalitis: Misdiagnosis, misconceptions, and how to avoid them. JAMA Neurol 80:12–14. https://doi.org/10.1001/jamaneurol.2022.4154
Damelang T, de Taeye SW, Rentenaar R, Roya-Kouchaki K, de Boer E, Derksen NIL, van Kessel K, Lissenberg-Thunnissen S, Rooijakkers SHM, Jongerius I, Mebius MM, Schuurman J, Labrijn AF, Vidarsson G, Rispens T (2023) The influence of human IgG subclass and allotype on complement activation. J Immunol 211:1725–1735. https://doi.org/10.4049/jimmunol.2300307
Article CAS PubMed PubMed Central Google Scholar
Dunstan EJ, Winer JB (2006) Autoimmune limbic encephalitis causing fits, rapidly progressive confusion and hyponatraemia. Age Ageing. 35:536–537. https://doi.org/10.1093/ageing/afl045
Finke C, Prüss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, Münte T, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T (2017) Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies. JAMA Neurol 74:50–59. https://doi.org/10.1001/jamaneurol.2016.4226
Fischl B (2012) FreeSurfer Neuroimage 62:774–781. https://doi.org/10.1016/j.neuroimage.2012.01.021
Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, Flanagan EP, McKeon A, Jenkins SM, Lennon VA, Pittock SJ (2018) Elevated LGI1-IgG CSF index predicts worse neurological outcome. Ann Clin Transl Neurol 5:646–650. https://doi.org/10.1002/acn3.561
Article CAS PubMed PubMed Central Google Scholar
Graus F, Vega F, Delattre JY, Bonaventura I, Rene R, Arbaiza D, Tolosa E (1992) Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 42:536–540. https://doi.org/10.1212/WNL.42.3.536
Article CAS PubMed Google Scholar
Greguletz P, Plötz M, Baade-Büttner C, Bien CG, Eisenhut K, Geis C, Handreka R, Klausewitz J, Körtvelyessy P, Kovac S, Kraft A, Lewerenz J, Malter M, Nagel M, von Podewils F, Prüß H, Rada A, Rau J, Rauer S, Rößling R, Seifert-Held T, Siebenbrodt K, Sühs KW, Tauber SC, Thaler F, Wagner J, Wickel J, Leypoldt F, Rittner HL, Sommer C, Villmann C, Doppler K (2024) Different pain phenotypes are associated with anti-Caspr2 autoantibodies. J Neurol 271:2736–2744. https://doi.org/10.1007/s00415-024-12224-4
Article CAS PubMed PubMed Central Google Scholar
Guery D, Cousyn L, Navarro V, Picard G, Rogemond V, Bani-Sadr A, Shor N, Joubert B, Muñiz-Castrillo S, Honnorat J, Rheims S (2022) Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies. J Neurol 269:5061–5069. https://doi.org/10.1007/s00415-022-11162-3
Article CAS PubMed Google Scholar
Helmstaedter C, Lendt M, Lux S (2000) VLMT: Verbaler Lern- und Merkfähigkeitstest. Testhandbuch. Hogrefe, Göttingen.
Huijbers MG, Querol LA, Niks EH, Plomp JJ, van der Maarel SM, Graus F, Dalmau J, Illa I, Verschuuren JJ (2015) The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol 22:1151–1161. https://doi.org/10.1111/ene.12758
Article CAS PubMed Google Scholar
Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C, Vincent A (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72:241–255. https://doi.org/10.1002/ana.23577
Isenman D, Dorrington K, Painter R (1975) The structure and function of immunoglobulin domains: II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement. J Immunol 114:1726–1729
Article CAS PubMed Google Scholar
Klang A, Schmidt P, Kneissl S, Bago Z, Vincent A, Lang B, Moloney T, Bien CG, Halasz P, Bauer J, Pakozdy A (2014) IgG and complement deposition and neuronal loss in cats and humans with epilepsy and voltage-gated potassium channel complex antibodies. J Neuropathol Exp Neurol 73:403–413. https://doi.org/10.1097/NEN.0000000000000063
Article CAS PubMed Google Scholar
Koneczny I (2018) A new classification system for IgG4 autoantibodies. Front Immunol 9:97. https://doi.org/10.3389/fimmu.2018.00097
Article CAS PubMed PubMed Central Google Scholar
Kong X, Gong X, Li A, Liu Y, Li X, Li J, Zhou D, Hong Z (2023) Efficacy of immunotherapy and prognosis in anti-LGI1 encephalitis patients: a meta-analysis. Ann Clin Transl Neurol 10:1578–1589. https://doi.org/10.1002/acn3.51847
Article CAS PubMed PubMed Central Google Scholar
Kuehn JC, Scheuerle A, Bauer J, Becker AJ, Wirtz R, Lewerenz J (2020) A 64-year-old patient with a mesiotemporal mass and symptomatic epilepsy. Brain Pathol 30:413–414. https://doi.org/10.1111/bpa.12818
Article PubMed PubMed Central Google Scholar
Lim J-A, Lee S-T, Moon J, Jun J-S, Kim T-J, Shin Y-W, Abdullah S, Byun J-I, Sunwoo J-S, Kim KT, Yang T-W, Lee W-J, Moon H-J, Kim DW, Lim BC, Cho YW, Yang T-H, Kim HJ, Kim Y-S, Koo YS, Park B, Jung K-H, Kim M, Park K-I, Jung K-Y, Chu K, Lee SK (2019) Development of the clinical assessment scale in autoimmune encephalitis. Ann Neurol 85:352–358. https://doi.org/10.1002/ana.25421
Malter MP, Frisch C, Schoene-Bake JC, Helmstaedter C, Wandinger KP, Stoecker W, Urbach H, Surges R, Elger CE, Vincent AV, Bien CG (2014) Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol 261:1695–1705. https://doi.org/10
留言 (0)